Idarubicin, cytarabine in standard or high-dose, and etoposide +- lenograstim (G-CSF). Combinations giving high remission rates in acute myeloid leukaemia
conference contribution
posted on 2023-05-23, 19:25authored byRaymond Lowenthal, Bradstock, KM, Matthews, JP, Enno, A, Gill, D, Page, FJ, Kim RooneyKim Rooney, Taylor, KM
No description available
History
Pagination
162
Department/School
Tasmanian School of Medicine
Publisher
Proceeding
Event title
VIII Congress Asian Pacific Division International Society of Haematology, October